Overview / Abstract: |
Target Audience Program Overview Learning Objectives Outline current and emerging molecular biomarkers that facilitate treatment personalization in NSCLC |
Expiration |
Jun 23, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
2.0 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Charu Aggarwal, MD, MPH |
Sponsors / Supporters / Grant Providers |
Amgen, AstraZeneca, Daiichi Sankyo, Inc., Genentech, Inc., Illumina, Inc., Novartis Pharmaceuticals Corporation and Turning Point Therapeutics, Inc |
Keywords / Search Terms |
Relias LLC Relias, Free CME, NSCLC Free CE CME |